Clinical Trial Update: REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children [Phase 3]

View source ↗

Summary

Phase 3 trial comparing REVAXIS® to DT Polio® as a second booster in 6-year-old children for diphtheria, tetanus, and poliomyelitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Poliomyelitis
• Tetanus

Drugs mentioned

• DT Polio®
• Revaxis (Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus Vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED